Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon

BACKGROUND: Combined pegylated interferon-α and ribavirin therapy has sustained virological response (SVR) rates of 54% to 61%. Pretreatment predictors of SVR to interferon therapy have not been fully investigated yet. The current study assesses a group of chemokines that may predict treatment respo...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Zekri, Abdel-Rahman N, Bahnassy, Abeer A, Mohamed, Waleed S, Alam EL-Din, Hanaa M, Shousha, Hend I, Zayed, Naglaa, Eldahshan, Dina H, Abdel-Aziz, Ashraf Omar
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: BioMed Central 2013
विषय:
Research
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC3707769/
https://ncbi.nlm.nih.gov/pubmed/23816271
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1743-422X-10-218
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन